DANAHER
Live / Applied — Third extension granted (statement of use) (as of 19 Dec 2025)
What this means for you
Not registered yet, but its 05 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97781429
- Mark type
- Design + words
- Filed
- 05 Feb 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Pamela B. Huff
Goods and services
- Class 001 — Chemicals: Industrial chemicals; Chemical preparations for scientific purposes, other than for medical or veterinary use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, inherited and infectious diseases; Chemical additives for use in the manufacture of pharmaceuticals; Assays for research purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, inherited and infectious diseases; Medical assays for testing of body fluids
- Class 007 — Machines and machine tools: Industrial machinery for pharmacy processing, namely, industrial mixer for mixing liquids in the pharmaceutical industry, pharmaceutical production machines for producing biological solutions, and machines used for process filtration in the pharmaceutical industry
- Class 009 — Scientific and electric apparatus: Downloadable computer software for information management in the field of healthcare; Downloadable computer software for microscope imaging; Computer hardware; scientific apparatus and instruments, namely, spectrophotometers for measuring relative DNA, RNA and protein, microscopes, microplate readers, cellular imaging systems for analyzing biological samples for scientific, research, and laboratory purposes, amplifiers, digitizers, chromatography columns, tubes, and well-plates being plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use
- Class 010 — Medical apparatus: Diagnostic medical equipment being medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, viruses, and inherited and infectious diseases; Medical diagnostic instruments for the analysis of body fluids or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic devices used in connection with patients for separating, detecting, analyzing, transporting, monitoring and measuring materials in fluid and solid patient samples, and parts therefor; Medical apparatus and instrument for diagnostic use, namely, molecular analysis instruments, cytometers, hematology analyzers, microbiology analyzers, particle and cell size analyzers, sample preparation devices, microbial identification and susceptibility testing instruments, urine analyzers, chemistry analyzers, immuno-assay apparatus and instruments, tissue staining instruments, and automated blood banking analyzers; Clinical and medical equipment for diagnostic purposes, namely, apparatus for nucleic acid amplification, analysis, labeling and detection; Medical diagnostic apparatus and instruments, namely, tissue processors for performing histological and cytological tissue processing including fixing, dehydrating, clearing and embedding tissue; personal protective equipment, namely, masks for use by medical personnel
- Class 042 — Scientific and technological services: Computer software design services; software as a service (SaaS) services featuring software for workflow management in the field of healthcare; Providing temporary use of online non-downloadable software for data analysis, data processing and data manipulation in the field of healthcare
Owner
- Danaher Corporation, Washington, DC, US
- Danaher Corporation, Washington, DC, US
Prosecution history
- 19 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2025 — SOU EXTENSION 3 GRANTED
- 17 Dec 2025 — SOU EXTENSION 3 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2025 — CORRECTED NOA E-MAILED
- 18 Nov 2025 — CORRECTED NOA E-MAILED
- 18 Nov 2025 — DIVISIONAL PROCESSING COMPLETE
- 12 Jun 2025 — DIVISIONAL REQUEST RECEIVED
- 12 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 11 Jun 2025 — SOU EXTENSION 2 GRANTED
- 11 Jun 2025 — SOU EXTENSION 2 FILED
- 11 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED